Skadden is representing MDS Inc. in connection with its definitive agreement with Danaher Corp. to acquire the analytical technologies division of MDS. The $650 million deal was announced September 2, 2009. MDS Inc. is a global life sciences company providing products and services for the development of drugs, and the diagnosis and treatment of disease.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates